Mechanistic considerations on the wavelength-dependent variations of UVR genotoxicity and mutagenesis in skin: the discrimination of UVA-signature from UV-signature mutation by Hironobu Ikehata
Mechanistic considerations on the
wavelength-dependent variations of UVR
genotoxicity and mutagenesis in skin: the
discrimination of UVA-signature from
UV-signature mutation
著者 Hironobu Ikehata
journal or
publication title
Photochemical & Photobiological Sciences
volume 17
number 12
page range 1861-1871
year 2018-05-14
URL http://hdl.handle.net/10097/00125833
doi: 10.1039/C7PP00360A
 1 
Mechanistic considerations on the wavelength-dependent variations of 
UVR genotoxicity and mutagenesis in skin: Discrimination of UVA-
signature from UV-signature mutation 
 
Hironobu Ikehata 
 
Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 
Sendai, Japan. 
E-mail: ikehata@med.tohoku.ac.jp; Tel: +81-22-717-8085; Fax: +81-22-717-8090 
 2 
Abstract 
Ultraviolet radiation (UVR) predominantly induces UV-signature mutations, C ® T and 
CC ® TT base substitutions at dipyrimidine sites, in the cellular and skin genome, 
although these UVR-specific mutations show a wavelength-dependent variation in their 
sequence-context preference, as evidenced by our in vivo mutation studies of mouse 
skin. The C ® T mutation occurs most frequently in the 5’-TCG-3’ context regardless 
of the UVR wavelength, but is recovered more preferentially there as the wavelength 
increases, resulting in prominent occurrences exclusively at the TCG context in the 
UVA wavelength range, which I will designate as a “UVA signature” in this review. 
The preference of the UVB-induced C ® T mutation for the sequence contexts shows a 
mixed pattern of UVC- and UVA-induced mutations, and a preference pattern similar to 
the UVB-induced one is also observed for natural sunlight, in which UVB is the most 
genotoxic component. In addition, the CC ® TT mutation hardly occurs at UVA1 
wavelengths, although it is detected rarely but constantly in the UVC and UVB ranges. 
These wavelength-dependent, sequence-context preferences of the UVR-specific 
mutations could be explained by two different photochemical mechanisms of 
cyclobutane pyrimidine dimer (CPD) formation. The UV-signature mutations observed 
in the UVC and UVB ranges are known to occur mainly through error-free translesion 
DNA synthesis (TLS) by DNA polymerase h across deaminated cytosines in CPDs, 
which are produced through the conventional singlet/triplet excitation of pyrimidine 
bases by the direct absorption of UVC/UVB photon energy in those bases. On the other 
hand, a novel photochemical mechanism through the direct absorption of UVA energy 
to double-stranded DNA, which is called “collective excitation”, has been proposed for 
the UVA-induced CPD formation. The UVA photons directly absorbed by DNA cause 
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CPD formation with a sequence context preference different from those caused by the 
UVC/UVB-mediated singlet/triplet excitation, producing CPDs preferentially at 
thymine-containing dipyrimidine sites, and probably also preferably at methyl CpG-
associated dipyrimidine sites. Cytosine deamination in these CPDs, which is known to 
be accelerated for CPDs formed at the TCG context, can lead to the UVA-signature 
mutations through the DNA polymerase h-dependent, error-free TLS. 
   
Introduction 
Action spectrum analysis of the mouse skin cancer induction by ultraviolet radiation 
(UVR), which was performed mainly by Jan C. van der Leun’s group, clearly 
demonstrated that the genotoxicity of UVR for mammalian skin depends on the 
wavelength, and suggested that, although the UVB component plays a major role in the 
genotoxicity, UVA, the longer wavelength components of UVR (320–400 nm), also 
makes a small but distinct contribution.1 The genotoxicity of UVR induces mutation in 
the skin genome, which can result in the carcinogenesis as evidenced by p53 mutations 
in skin cancers in sun-exposed areas of human skin2–5 and those experimentally induced 
in mouse skin.6–11 The mutagenicity of UVR is derived from its ability to produce DNA 
damage by direct or indirect photochemical reactions with DNA and/or by indirect 
oxidative DNA modifications through the formation of reactive oxygen species 
(ROS).12 The former reactions produce UVR-specific base photolesions such as 
cyclobutane pyrimidine dimers (CPDs) and pyrimidine(6-4)pyrimidone photoproducts 
(64PPs) at dipyrimidine sites in DNA.13 The latter oxidative modifications include 
single strand DNA breaks and the formation of oxidative base damage such as 8-
hydroxyguanine (8OH-G).14 The contribution of the oxidative DNA modification to the 
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UVR genotoxicity has been noticed especially for UVA, where the efficiency of 
photolesion production by direct photochemical reactions is reduced by several orders 
of magnitude compared to the shorter wavelengths of UVR.12,14–16 However, 
quantitative and mechanistic analyses of UVA-induced CPD formation in the last two 
decades have provoked a reconsideration on the origin of the UVA genotoxicity.17–25 
I have studied UVR-induced mutation spectra in mouse skin using a transgenic 
mouse strain with l-phage vector-based, bacterial lacZ-transgenes, which were 
developed for mutation analysis, and a variety of UVR sources emitting different 
wavelength components from UVC to UVA (Fig. 1A).26–31 In this review, I provide an 
updated overview of the wavelength-dependent UVR genotoxicity mainly based on the 
mutation spectra obtained by in vivo analyses, and propose a model explaining the 
mechanism of wavelength-dependent variations in the mutation spectra by combining 
some recent findings in DNA repair, photochemistry and photobiology.  
 
Wavelength dependence of UVR-induced mutation spectra 
UVR induces specific types of mutation in DNA as reported for phages,32–34 
bacteria,35,36 yeasts,37–39 mammalian cultured cells40–50, and mammalian skin.26–31,51,52 
These UVR-specific mutation types include the C ® T transition at dipyrimidine sites 
and CC ® TT tandem base substitution, which are called collectively “UV signature” 
as discriminative mutations indicating the trace of UVR genotoxic insults.2 All UVR 
components, UVC (wavelengths <280 nm), UVB (280–320 nm), UVA2 (320–340 nm) 
and UVA1 (340–400 nm), can induce the UV-signature mutations as demonstrated in 
our studies,26–31,53 summarized in Fig. 1B and C, although the wavelengths in the UVA1 
region hardly induced CC ® TT mutations.29,30 Our studies revealed that the C ® T 
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transition at dipyrimidine sites is the dominant type for all UVR components, 
comprising 59–84% of total mutations observed after irradiation, demonstrating that 
UVR genotoxicity results mostly from DNA photolesions specifically produced by 
UVR.54 On the other hand, the influence of UVR-produced ROS is not remarkable or, if 
any, minor in the UVR-induced mutation spectra, judging from the contribution of G ® 
T transversion, a mutation that can be caused by 8OH-G, one of the representative types 
of oxidative DNA damage.55 Only in the sunlight-induced spectrum, the G ® T 
mutation was significantly induced, although it was a minor component,28 which might 
suggest some contribution of non-UVR wavelengths included in sunlight to the skin 
genotoxicity as also observed in other studies with yeast and phage.38,39,56 Some 
photodynamic reactions might be relevant. Moreover, it should be noted that UVA1 
sources, both the broadband UVA1 lamps and narrowband UVA1 laser, did not induce 
oxidative damage-related mutations such as G ® T and G ® C transversions57 at a 
remarkable frequency,29,30 although a dose-dependent formation of 8OH-G was 
observed in the skin after UVA1 irradiation,29 as observed in cultured cells.15 It is also 
known that 8OH-Gs are removed from cellular DNA much faster than CPDs.58 These 
observations strongly support that UVR exerts its genotoxicity to the skin mainly 
through direct photochemical reactions with DNA, irrespective of its wavelength 
component. In addition, the ROS-mediated genotoxicity by UVR should be studied with 
caution, especially in in vitro studies, because artificial ingredients in the DNA solvent 
or cell/tissue culture media could cause or promote the production of ROS upon UVR 
irradiation.17,59 To avoid these artifacts, analyses in vivo such as in the skin would be 
preferable. This is one of the reasons I have excluded the cell-based studies from my 
consideration of the UVR-induced mutation spectra in this review, although some 
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important, contradicting points shown in those studies are discussed below. A more 
detailed discussion on the disadvantages of the use of cell-based, in vitro mutation 
assays for the study of mammalian UVR-induced mutation spectra has already been 
made.60 However, most of the studies with skin mentioned above examined only the 
UVR genotoxicity for normal skin after an acute single exposure. Multiple/chronic 
UVR exposures or exposures of the skin under pathological conditions could bring a 
ROS-mediated genotoxicity in addition to the genotoxicity mediated by direct 
photochemical reactions with DNA. Interestingly, it has been demonstrated that CPDs 
can be produced by ROS generated from melanin derivatives chemically excited long 
after UVR exposure, which suggests that ROS could also induce UV-signature 
mutations.61 However, melanocytes usually reside in the dermal layer in mouse skin, 
and melanin is poor in the mouse epidermal layer, so that such mutations induced by 
ROS-produced CPDs would be difficult to detect with the current in vivo mutation 
assay system using transgenic mice. 
 
Mutation induction mechanism by UVR-induced photolesions 
The molecular mechanism of the mutagenesis by UVR-specific photolesions has been 
studied widely and elucidated fairly well for some aspects.54 The mutation induction by 
UVR requires replicative DNA synthesis after irradiation.62–64 CPD and 64PP are both 
replication-blocking DNA damage, so that they should be removed by DNA repair 
before a replication fork encounters them,65 or should be overcome by some damage 
tolerance mechanisms so that the replicational DNA synthesis can be continued over the 
damage site, because a failure in replication can lead to cell death.66,67 One of the 
damage tolerance pathways could be a recombinational bypass of these photolesions by 
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detouring the damage on the template strand using the genetic information of the other, 
newly replicated daughter strand.66,67 This pathway would be error-free, but should be 
too elaborate to perform the over-damage replication efficiently. Delay in DNA 
replication, which leads to delay in cell proliferation, could cause a deficiency in the 
recovery of damaged tissues. Another tolerance pathway is translesion DNA synthesis 
(TLS), which can pass directly over the lesions on the template strand with the help of 
specialized DNA polymerases, TLS polymerases.54,68,69 In the TLS mechanism, 
replicative DNA polymerases switch to TLS polymerases upon an encounter with 
replication-blocking DNA damage, and the TLS polymerases continue DNA synthesis 
opposite the DNA damage, usually ignoring the base-pairing rule of nucleic acids. After 
the replication fork has passed across the damage, replicative polymerases take over the 
DNA synthesis in place of TLS polymerases and continue DNA replication. Thus, in 
the mechanism of damage tolerance by TLS, the DNA replication could be continued 
efficiently at the damage site in a manner sufficient to assist the recovery of damaged 
tissues, although the DNA synthesis by TLS would usually be error-prone.  Actually, it 
was suggested that sites with repair-resistant CPDs in the p53 gene are also frequently 
mutated sites in human skin cancers.70 
Among the TLS polymerases, however, DNA polymerase h (polh) is exceptional. 
Polh can synthesize a daughter strand error-free across a CPD on the template strand, 
probably by using the base pairing ability remaining in CPDs,71,72 thus rather 
suppressing mutation induction by CPDs. This error-free TLS ability of polh appears 
CPD-specific because polh can hardly bypass 64PPs or bypass other types of base 
damage less error-free than CPDs.73–76 However, this polh-dependent error-free TLS 
itself causes the UVR-specific mutations. It is known that cytosines in CPDs are highly 
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prone to deaminate at position 4 and change easily to uracils (or a thymine if the 
cytosine is methylated at position 5), which results in the conversion of cytosine-
containing CPDs to uracil or thymine-containing ones.77–80 If a replication fork 
encounters such deaminated CPDs, the error-free TLS by polh should insert adenine 
opposite the deaminated cytosine, namely uracil or thymine, thus resulting in the 
induction of UVR-specific C ® T and CC ® TT mutations (Fig. 2). Since CPD has 
been demonstrated to be the main mutagenic UVR photolesion in normal mammalian 
cells and skin,81,82 the error-free TLS opposite deaminated CPDs by polh should be the 
major pathway in the induction of UVR mutations in repair-proficient cells and skin. 
In the absence of polh, UVR can induce mutations in cells and skin at much 
higher frequencies than in the presence, although the mutation spectrum still shows the 
UV signature predominantly.53,83–86 This polh-independent UVR mutagenesis has been 
explained by a mechanistic model called the “two-step model”, in which inserter and 
extender DNA polymerases are involved in the TLS.54,87–89 These DNA polymerases 
might include polymerase i, k, z, Rev1 as well as h,54,71,90,91 which are TLS 
polymerases, and replicative DNA polymerases such as d.92 64PPs and Dewar isomers, 
as well as CPDs, could induce UV-signature mutations by this “two-step” mechanism 
because the base insertions opposite photolesions by this mechanism is supposed to 
occur according to the “A-rule”, in which an adenine is inserted with the base pairing 
rule ignored.54,93,94 Although strongly supportive genetic studies have been reported,87–
89 the two-step model for the mutagenesis with UVR photolesions is, however, still 
presumptive, awaiting experimental demonstrations by biochemically reconstituted 
systems. Another UVR-specific mutation that could be explained by the two-step model 
is the triplet mutation, a mutation with multiple base substitutions or frameshifts within 
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a three-nucleotide sequence that includes a dipyrimidine sequence.54 The triplet 
mutations were detected frequently in UVB-exposed mouse skin deficient in the 
nucleotide excision repair,95–98 whereas the same mutations have also been detected in 
other systems including mammalian cultured cells and skin cancers, although their 
frequencies are variable depending on their repair abilities.99 The multiple base 
substitutions and frameshifts occurring around a dipyrimidine site are easy to explain by 
multiple misincorporations by inserter and extender DNA polymerases in the two-step 
model.54 
 
Variation of sequence context preference of the UVR-specific C ® T mutation by 
wavelength 
Although the mutation spectrum induced by each component of UVR shows a similar 
pattern of UV-signature mutations (Fig. 1B, C), we found that the sequence context 
preference of those UVR-specific mutations was remarkably different among UVR 
components, as reported in our studies with transgenic mice,30,31 which are summarized 
in Fig. 3A. We focused on three-tandem-base sequences in which the UVR-specific C 
® T mutation occurs at the center base. There are 12 types of such triplet sequences, 
which possess a cytosine base at the center and also include one or two dipyrimidine(s). 
We found that UVR-specific C ® T mutations occurred preferably at the 5’-TCG-3’ 
(TCG) context in the lacZ transgene, 26–31 particularly with exposure to longer 
wavelength components of UVR.27,29,30 Although the mutations at the TCG context 
were most frequent among all the triplet contexts regardless of the UVR source, their 
contribution to the mutation spectrum was moderate with the UVC source but 
prominent exclusively with the UVA sources (Fig. 3A).31 Especially, with the UVA1 
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sources more than 80% of the UVR-specific C ® T mutations occurred at the TCG 
context. In the UVB range, the mutations at the TCG context were fairly conspicuous 
but not as prominent as those by UVA, which were intermediate between UVC and 
UVA. The distribution of occurrences of the UVR-specific mutation by sunlight was 
relatively similar to that by UVB, reflecting the fact that UVB is the component in 
sunlight most genotoxic to the skin.1,100–103 Thus, the occurrence of the UVR-specific C 
® T mutation at the TCG context becomes conspicuous gradually as the wavelength 
increases, finally overwhelming those at the other triplet contexts at UVA1 wavelengths 
(Fig. 3A). Based on these observations, I propose that the UVR-specific C ® T 
mutation that occurs preferentially at the TCG context should be called the “UVA 
signature”. Although we proposed previously to call this type of mutation the “solar-UV 
signature”,30,60 which we featured as a kind of the UVR-specific mutation that occurs 
preferably at methyl CpG-associated dipyrimidine sites, the context preferences of the 
sunlight- and UVB-induced mutations were rather a mixture of those of UVC and UVA, 
as shown in Fig. 3A. Thus, “UVA signature” is more appropriate as a designation for 
the TCG-preferential UVR-specific mutation. 
Since, as mentioned above, UVR mutagenesis occurs in a polh-dependent manner 
in normal cells and skin (see Fig. 2), we examined how the defect in polh affects the 
TCG preference of the UVR-specific mutation.53 We found that the polh deficiency 
made the mutation lose the TCG preference, as shown in Fig. 3B, clearly demonstrating 
that the sequence context preference of the mutation depends on the TLS by polh, and 
suggesting that the TCG preference of the mutation should reflect the preferable 
formation or deamination of CPDs at some specific sequence motifs, which should at 
least overlap with the TCG sequence. 
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The mechanisms inducing two types of UVR-specific mutation, UV signature and 
UVA signature 
As shown in Fig. 1, the mutation spectra with UV-signature mutations can be induced 
by any components of UVR, whereas the mutation spectra with UVA-signature 
mutations, namely the exclusive occurrences at the TCG context of UVR-specific C ® 
T mutations, are manifested specifically in the UVA range. Since both signature 
mutations are induced by TLS over deaminated CPDs by polh as mentioned above, then 
what causes the difference between them? UVA is known to induce CPDs significantly 
although not as efficiently as UVC,17,18,21,104 but in a distribution pattern among 
dipyrimidine motifs different from those by UVC and UVB.19,20,22 UVA, more 
specifically UVA1, produces CPDs of TT dipyrimidines (TT-CPDs) at much higher 
frequencies and CPDs of 5’-TC-3’ (TC) and 5’-CT-3’ (CT) dipyrimidines (TC- and CT-
CPDs) at lower frequencies than the shorter UVR components, although it does not 
produce detectable amounts of CPDs of CC dipyrimidines (CC-CPDs).20,22 
Accordingly, CC ® TT mutations were not detected in our UVA1-induced mutations in 
mouse skin.29,30 It was supposed that the mechanism of CPD formation by UVA was 
different from that by the shorter UVR, and that a triplet energy transfer to DNA bases 
from some endogenous photosensitizers that can be activated by UVA energy would 
mediate the CPD formation in the UVA range, because the energy of UVA photons is 
not sufficient to directly activate pyrimidine bases to their excited singlet states, which 
is necessary to cause photochemical reactions.20,105 However, such photosensitizers 
have not been identified in vivo so far, and direct CPD formations in DNA by UVA1 
have been demonstrated in experiments with isolated DNA.17,23,106,107 Recently, another 
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mechanism by which UVA directly produces CPDs was proposed,108,109 in which the 
UVA energy is absorbed directly to double-stranded DNA through “collective excited 
states”, which can be followed by redistribution of the energy to pyrimidine bases 
leading to CPD formation. On the other hand, UVC, and probably UVB, should 
produce CPDs principally through the conventional singlet/triplet excited states induced 
by direct absorption of the photon energy to pyrimidine bases,110,111 although some 
minor contribution of the collective excitation would also be probable. Thus, UVA and 
UVC/UVB could both produce CPDs directly, but through different photochemical 
mechanisms (Fig. 4).105 
It has been shown that UVB and/or solar UVR produce CPDs preferably at CpG-
associated dipyrimidine sites.112–114 The CpG motif is the target sequence of mammalian 
DNA methylation that modifies cytosine to 5-methylcytosine (mC).115 This CpG 
preference of CPD formation requires CpG methylation,113,114 and is not observed for 
UVC.114,116,117 The CpG-associated dipyrimidine sites are 5’-TCG-3’ and 5’-CCG-3’, 
the former of which is also the target context of the UVA-signature mutation. As 
mentioned above, UVA produces predominantly TT-CPDs along with small amounts of 
TC- and CT-CPDs, in other words, preferentially induces thymine-containing CPDs. 
The molecular structure of 5-methylcytosine is similar to that of thymine, which would 
raise the possibility that UVA produces CPDs not only from thymine but also from 5-
methylcytosine, probably in the order of dipyrimidine preferences of TT ≥ TmC > TC > 
CT ≥ CmC (Fig. 4). Although the preferable CPD formation at 5’-TmCG-3’ and 5’-
CmCG-3’ contexts (TmCG and CmCG) has not been demonstrated for UVA so far, the 
methyl CpG (mCpG)-directed CPD formation was much more remarkable after 
exposure to sunlight than to UVB with 5 to 15-fold increases by sunlight and 1.7 to 1.8-
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fold by UVB compared to UVC-induced formation,113,114 suggesting some contribution 
of the UVA component. If we accept the hypothesis that UVA should produce CPDs 
preferably at mCpG-associated dipyrimidine sites, the TCG preference of the UVA-
signature mutation can be easily explained. However, there is one perplexing matter. If 
UVA can also produce CPDs at the CmCG context, why don’t the mutations at the 
same context contribute remarkably to the UVA-signature mutation? 
It has been demonstrated that the propensity of cytosine deamination in CPDs 
depends on the sequence context in which the CPD resides.118 CPDs in the CmCG 
context are 50-fold slower to deaminate than those in the TCG and TmCG contexts, 
which are most prone to deaminate with a half-life of around 6 hours in double-stranded 
DNA, as far as examined so far. This difference in the CPD deamination propensity can 
explain the poor recoveries of UVR-specific mutations in the CCG context after UVA 
exposure that was reported in our studies using mouse skin (Fig. 3A),27,29,30 in which all 
the mutation-detected CpG sites in the mutational target lacZ transgene were confirmed 
to be fully methylated.26,119 Consequently, the preferential mutation occurrences at the 
TCG context characteristic for the UVA-signature mutation can be rationalized by the 
preferable CPD formation at mCpG-associated dipyrimidine sites and the context-
dependent propensity of CPD deamination under the mutation mechanism of the error-
free TLS by polh (Fig. 4). 
Moreover, the context-dependent CPD deamination affects not only the UVA-
signature, but also the UV-signature mutations. As shown in Fig. 3A, the UVR-specific 
mutation was most frequent at the TCG context even in the UVC and UVB ranges, 
although their occurrence ratios were not as conspicuous as those in the UVA range. In 
these shorter UVR ranges, the mCpG-preferable CPD formation, which should be 
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mediated through the collective excitation mechanism, would be less remarkable than in 
the longer UVR ranges, probably overwhelmed by abundant CPDs produced by the 
singlet/triplet excitation mechanism, which functions dominantly in the UVC and UVB 
ranges but almost completely fades out in the UVA1 range. Thus, CPD formation at the 
TCG context would not be so prominent in the UVC and UVB ranges as in the UVA 
range. However, once CPDs are formed at the TCG context, they should deaminate 
efficiently and could cause mutations by the polh-dependent TLS mechanism, resulting 
in the distribution of mutation occurrences among the triplet contexts shown in Fig. 3A. 
The mutation occurrence distribution observed in the absence of polh (Fig. 3B) might 
reflect the distribution of CPD formations among the triplet contexts, if we suppose that 
the mutation induction occurs randomly through the TLS over UVR photolesions by 
other error-prone TLS polymerases with the mechanism of the two-step model. This, 
however, remains to be demonstrated. 
The TCG preference of UVR-induced mutations was also demonstrated by an 
exome analysis of 74 cancer-related genes in human sun-exposed normal and three 
types of cancerous skin tissues, in which the most frequent and overwhelming mutation 
was C ® T transitions, which occurred predominantly at the TCG context with fewer 
occurrences at the other dipyrimidine-containing triplet contexts, regardless of the skin 
tissue type.120 This result corresponds well with our observations on the occurrence 
distribution of the sunlight-induced UVR-specific mutations among the triplet contexts 
shown in Fig. 3A.28 Thus, the TCG preference of UVR-induced mutations is neither an 
experimental artifact nor an observation limited to the lacZ transgene in mouse. It 
occurs both in mouse and human, and would occur in other organisms with cytosine 
methylation in their genome as far as they possess polh-like TLS polymerases. 
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Although an exceptional case was reported for p53 gene mutations in human skin 
cancers, which were detected rather more frequently in the CCG context than in TCG,2–
5,30,121 this discrepancy has not been observed for the p53 mutations in mouse skin 
cancers,6–11 and can be explained by the poverty of mutable TCG sites in the human p53 
gene on the transcribed strand, as discussed in detail previously.30 The lack of mutable 
TCG sites in human p53 gene further suggests that the human genome have evolved to 
prevent solar UVR from inducing malignant mutations by substituting genetically 
important but UVR-vulnerable TCG sites with other genetically equivalent and UVR-
refractory sequences. This evolution would be promoted by the human features of 
hairless skin and diurnal activity under the threat of photochemically genotoxic UVR 
components in natural sunlight. 
 
Studies inconsistent with the UVA-signature hypothesis 
My proposal for the UVA-signature mutation is based on the CPD formation 
mechanism through the collective excited state-mediated photochemistry, with which 
CPDs should be produced preferably at thymine-containing dipyrimidine sites resulting 
in the paucity of CC-CPDs, which becomes evident after the exposure to UVA, 
especially UVA1. On the contrary, Rochette et al. reported the significant formation of 
CC-CPDs by UVA1 using a ligation-mediated PCR (LMPCR) method.19 However, the 
LMPCR method seems to have a tendency to overestimate the amounts of cytosine-
containing CPDs, especially that of CC-CPDs,19,122 compared with other methods such 
as chromatographic analyses,123 post-labeling CPD-specific enzymatic cleavage 
assays124,125 and HPLC with tandem mass spectrometry (HPLC-MS/ MS).126 Actually, 
little CC-CPD formation has been detected in DNA, cells and skin tissues exposed to 
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UVA1 with the HPLC-MS/MS, a far more sensitive, direct CPD detection 
method.20,22,23 In addition, the LMPCR image (Fig. 1) given in the paper by Rochette et 
al. showed distribution patterns of UVA-induced CPD formation among dipyrimidine 
sites clearly different from those induced by other UVR sources such as UVC, UVB 
and simulated sunlight.19 Although the bands corresponding to cytosine-containing 
dipyrimidine sites were easily discernible in the lanes for the shorter UVR sources, 
those were hardly distinguishable from the backgrounds in the UVA lanes, which would 
reduce the reliability of estimates of the amount of cytosine-containing CPDs for the 
UVA lanes. 
The paucity of CC-CPDs should also suppress the CC ® TT tandem mutations in 
the mutation spectrum induced by UVA, resulting in the lack of such tandem mutations 
in the UVA signature. Accordingly, in our studies, the tandem mutations were not 
observed in the mutations recovered from the mouse skin exposed to UVA1,29,30 
although they were detected after exposure to UVA2 (Fig.1),27 which would indicate 
that the singlet/triplet excitation mechanism for CPD formation are still valid in this 
wavelength range. Drobetsky et al. studied a UVA-induced mutation spectrum in the 
aprt gene using Chinese hamster cells and reported the induction of a unique type of 
mutation, T ® G transversion, which they named UVA fingerprint,46 although the 
preferable induction of such mutations has not been confirmed in subsequent studies 
except for one.127 In the same study, Drobetsky et al. also recovered a few CC ® TT 
mutations.46 Kappes et al. reported another UVA-induced mutation spectrum in the hprt 
gene using human primary fibroblasts, detecting again a few CC ® TT mutations.50 
Since both studies used short-cut filter-equipped UVR sources emitting mainly UVA1, 
they suggest that UVA1 could induce the tandem base substitutions, in contradiction to 
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my consideration given above. The recoveries of the tandem mutation in these studies 
might result from the significant contribution of the UVA2 component to the irradiated 
UVA, especially for the former study because they used blacklight lamps,46 which emit 
mainly UVA2 wavelengths that might leak through the short-cut filter. Moreover, both 
studies were performed with cultured cells, and irradiation to cultured cells often 
produces ROS depending on the ingredients of the cultured medium.17,59 It is known 
that ROS could induce CC ® TT mutations independently of UVR exposure,128,129 
especially in mononucleotidyl cytosine runs.130 Although the mechanism of the ROS-
mediated CC ® TT mutation is unknown, it could have affected the mutation spectra 
observed in these cellular studies. In addition, the use of aprt and hprt genes as 
mutational markers was not appropriate for the study of UVR-induced mutations in 
mammalian cells because both genes are hypomethylated and poor in mutable 
dipyrimidine-associated CpG sites, whereas collective excited state-mediated, UVR-
specific mutations are supposed to prefer mCpG sites as supported by our studies and 
p53 gene mutations in human and mouse skin cancers. The short size of coding 
sequences of both genes (543 and 657 bp) is also disadvantageous for mutation 
spectrum studies because of their low variation in sequence contexts (the lacZ transgene 
is 3090-bp long). These points have already been discussed in detail in our previous 
review.60 Reflecting these situations, the appearance of UV-signature mutations in the 
UVA-induced mutation spectra were much less remarkable in both the cellular studies 
(27–35%)46,50 than those in our studies with skin (59–68%),29,30 suggesting a much 
greater contribution of non-UVR-induced mutations to the spectra of the cellular 
studies. 
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Conclusion 
In my studies with mice, UVC induced the UVR-specific C ® T mutations most 
frequently at the TCG context but also at other cytosine-containing dipyrimidine 
contexts at comparable frequencies, whereas UVA induced the same mutations 
exclusively at the TCG context with rare mutations at the other contexts. The context 
preference of UVB-induced mutations showed a mixture between those of UVC and 
UVA. Based on the molecular mechanism of UVR mutagenesis that is mediated mainly 
through polh-dependent error-free TLS across deaminated CPDs, this wavelength-
dependent context preference of the mutations can be explained by deamination 
tendencies of cytosine-containing CPDs and a recently identified/proposed 
photochemical mechanism of CPD formation, the collective excitation, which would 
justify the discrimination of UVA-induced UVR-specific mutations as the UVA 
signature from the UV-signature mutations induced by UVC/UVB, which would be 
caused mainly by CPDs formed through the conventional photochemical mechanism of 
singlet/triplet excitation. 
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Figure legends 
 
Fig. 1  Mutation spectra in mouse skin epidermis induced by various UVR sources. (A) 
Profiles of percent spectral energy outputs of UVR sources used for my studies on 
induced mutation spectra in mouse skin. UVC: germicidal lamps (GL15, Hitachi, 
Japan);31 UVB: broadband UVB fluorescent lamps (FL20S.E, Toshiba, Japan);26 
sunlight: summer noon sunlight in Japan;28 UVA2: blacklight fluorescent lamps 
(FL20S.BLB, Toshiba, Japan) with a Mylar filter (the cut-off output is indicated by a 
shaded area);27 UVA1: Sellamed 2000 (Sellas, Germany);30 and 364-nm laser (National 
Institute for Basic Biology, Japan).29 (B)Mutation spectra induced in mouse epidermis 
by UVB, sunlight and UVA2.26–28,53 (C) Mutation spectra induced in mouse epidermis 
by UVC, UVA1 and 364-nm laser.29–31 Background is the mutation spectrum in the 
epidermis of unirradiated mice.26 The tandem base substitutions are mostly CC ® TT 
mutations, but those for the background and UVA1 do not include CC ® TT.26,30 PyPy, 
dipyrimidine. 
 
Fig. 2  The mechanism of UVR mutagenesis by error-free TLS across deaminated 
CPDs by DNA polymerase h. UVR can produce CPDs at dipyrimidine sites (PyPy): 5’-
TT-3’, 5’-TC-3’, 5’-CT-3’ and 5’-CC-3’ (TT, TC, CT and CC). DNA polymerase h 
(polh) can synthesize a DNA strand opposite a CPD on the template strand following 
the base pairing rule faithfully. Thus, translesion DNA synthesis (TLS) by polh can 
bypass CPDs error-free. However, cytosines in CPDs are unstable and easily deaminate 
to produce uracils, or thymines if the cytosine is methylated at position 5, converting a 
cytosine or 5-methylcytosine-containing CPD (C-CPD or mC-CPD) to an uracil or 
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thymine-containing CPD (U-CPD or T-CPD), which can induce the UV-signature 
mutations upon the “error-free” TLS by polh, although polh could bypass CPDs 
without inducing mutations if the deamination does not occur, as in the case of thymine 
dimer (TT-CPD). 
 
Fig. 3  Sequence context preference of the UVR-specific C ® T mutation. (A) The 
distributions of the occurrence ratios (%occurrence) of the UVR-specific mutations 
among triplet sequence contexts were compared among UVR sources. The occurrence 
ratios were estimated as ratios of the occurrences of the UVR-specific C ® T mutations 
at specific triplet contexts (shown in the box) to those at the total triplet contexts 
relevant to the mutation, which are cytosine-centered, dipyrimidine-containing three-
base sequences. UVR sources are the same as those in Fig. 1. Pu, purine; Py, 
pyrimidine. (B) UVB-induced distributions of the UVR-specific mutation among triplet 
contexts were compared between mice with polh proficient (Polh+/+) and deficient 
(Polh-/-). 
 
Fig. 4  A model of two independent, but overlapping mechanisms of the UVR-specific 
mutations of “UV signature” and “UVA signature”. The shorter (UVC/UVB) and 
longer (UVA) UVR components produce CPDs differently through two distinct 
photochemical reactions mediated by the singlet/triplet excitation of pyrimidine bases, 
which would function at shorter wavelengths up to the UVA2 range, and the collective 
excitation of double-stranded DNA, which could work throughout the whole UVR 
ranges, with different distributions in dipyrimidine composition: TT > TC > CT > CC 
for the former and TT >> TC > CT with CC undetectable for the latter, respectively. 
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The CpG methylation can also enhance the CPD formation by the collective excitation 
mechanism. The formation of CPD enhances the deamination of its cytosine, although 
the propensity of CPD deamination depends on the sequence context it resides in, 
showing the most efficient deamination in the TCG context. The “error-free” TLS by 
polh across the deaminated CPDs results in the induction of the UVR-specific 
mutations of the “UV signature”, C ® T and CC ® TT mutations at dipyrimidine sites, 
for the CPDs produced by the UVC/UVB-provoked singlet/triplet excitation and the 
“UVA signature”, the preferential induction of C ® T mutations at the TCG context, 
for the CPDs by the collective excitation, which becomes prominent in the UVA range. 
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